A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.

Abstract

BACKGROUND The treatment approaches to antineutrophil cytoplasmic autoantibody (ANCA) small vessel vasculitis expose patients to the risks associated with long-term use of corticosteroids and cytotoxic agents. In an effort to explore approaches to minimize risks, we conducted a pilot efficacy and safety study of mycophenolate mofetil (MMF) in the treatment… (More)

Topics

3 Figures and Tables

Cite this paper

@article{Joy2005APS, title={A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.}, author={M. S. Joy and Susan Lynn Hogan and John Charles Jennette and Ronald J. Falk and Patrick H. Nachman}, journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association}, year={2005}, volume={20 12}, pages={2725-32} }